“
“We read with much interest the article by Li et al.1 This elegant study indicated that intraportal transplantation of human bone marrow mesenchymal stem cells (hBMSCs) could achieve better liver function recovery and long-term survival in pigs with fulminant hepatic failure (FHF), whereas animals either in the sham group or receiving hBMSCs through the peripheral vein died within 4 days after D-galactosamine injection. We believe that the transplantation procedure was performed

immediately after the induction of liver failure according to the title, though interval time between the two interventions was not mentioned clearly in the Materials and Methods section. Because the immediate treatment might not be available for patients with FHF in the clinical setting, whether delayed hypoxia-inducible factor pathway treatment remains beneficial would be more significant, as proposed by other researchers.2 Given that pigs without cell transplantation could still survive for a mean of 2.9 days, we wonder whether the investigators examined the Barasertib nmr influence of different lengths of intervals on outcomes. The investigators also explored the mechanisms underlying the efficacy of intraportal hBMSC administration for FHF. It is encouraging to know that approximately

30% of hepatocytes are derived from hBMSCs 2-10 weeks after transplantation. On the other hand, BMSCs possess the ability to transdifferentiate into myofibroblasts that produce extracellular matrix (ECM) constituent and contribute to tissue repair.3 One recent study demonstrated that acute liver failure triggered the activation of hepatic stellate cells and enhanced the formation of ECM, which reciprocally provide an optimal architecture for support of hepatocyte repopulation.4 Among animals assigned to the intraportal transplantation selleck inhibitor group, an approximately and completely

healthy liver structure was exhibited at weeks 3 and 5, respectively. It is likely that hBMSC-derived parenchymal and nonparenchymal cells coevolve in facilitating the regenerative process. Do the investigators have histological data about transdifferentiation of hBMSCs into myofibroblasts, which would be of interest for further elucidation of mechanisms? Tao Wei M.D.* †, Yi Lv M.D., Ph.D.* †, * Department of Hepatobiliary Surgery, the First Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an, China, † Institute of Advanced Surgical Technology and Engineering, Xi’an Jiaotong University, Xi’an, China. “
“The prevalence of Helicobacter pylori-negative and non-steroidal anti-inflammatory drug (NSAID)-negative peptic ulcers, commonly known as idiopathic peptic ulcers (IPUs), has been reported to be very low (0.9–2.6%) in Japan based on data from the 1990s. However, recent trends have yet to be been reported.